Related Experiment Video
Updated: Apr 18, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Pyridine and pyridinone-based factor XIa inhibitors
James R Corte1, Tianan Fang1, Jon J Hangeland1
1Discovery Chemistry and Cardiovascular Biology, Research and Development, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, NJ 08543, United States.
Researchers explored six-membered ring replacements for imidazole scaffolds, discovering potent pyridine and pyridinone factor XIa inhibitors. This research clarifies key structural differences between these analogs.
Area of Science:
- Medicinal Chemistry
- Structural Biology
Background:
- The imidazole ring is a common scaffold in drug discovery.
- Understanding structure-activity relationships (SAR) is crucial for developing new therapeutics.
Purpose of the Study:
- To investigate six-membered ring replacements for the imidazole scaffold.
- To identify novel potent and selective inhibitors of factor XIa.
Main Methods:
- Synthesis of pyridine and pyridinone analogs.
- Structure-activity relationship (SAR) studies.
- X-ray crystallography to determine binding modes.
Main Results:
- Discovery of potent and selective pyridine (S)-23 and pyridinone (±)-24 factor XIa inhibitors.
- Detailed SAR data comparing six-membered rings to imidazole.
- X-ray crystal structures revealed key differences in binding interactions.
Conclusions:
- Six-membered ring replacements offer a viable alternative to imidazole scaffolds for factor XIa inhibitors.
- Understanding SAR and structural differences guides the design of more effective inhibitors.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Dipeptidyl Peptidase 4 Inhibitors
Inhibitors of Viral Protein Synthesis

